Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus

Sarah K Highlander1, Kristina G Hultén, Xiang Qin

  • 1Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA. sarahh@bcm.edu

BMC Microbiology
|November 8, 2007
PubMed
Abstract

Insights

Community acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) USA300 is a dominant pathogen. Genomic analysis reveals subtle genetic differences, not large gene acquisitions, likely explain its increased virulence and prevalence.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Community acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is a global health concern.
  • The USA300 clone is the predominant CA-MRSA strain in the United States, causing significant infections.
  • USA300 exhibits higher virulence than other CA-MRSA strains, but the underlying genetic factors are not fully understood.

Purpose of the Study:

  • To sequence and annotate the genomes of pediatric USA300 CA-MRSA and methicillin-susceptible Staphylococcus aureus (MSSA) isolates.
  • To identify genetic determinants contributing to the virulence and dominance of the USA300 clone.
  • To compare USA300 genomic features with other Staphylococcus aureus strains.

Main Methods:

  • Whole genome sequencing (WGS) using Sanger dideoxy and 454 Life Sciences pyrosequencing.
  • Rigorous annotation of the USA300 MRSA strain genome.
  • Comparative genomic analysis of USA300 isolates and other Staphylococcus aureus strains.

Main Results:

  • Sequenced two pediatric USA300 isolates (MRSA and MSSA) from Texas Children's Hospital.
  • Identified chromosomal open reading frames and plasmids in the USA300 MRSA strain.
  • Discovered two regions unique to USA300-MRSA, including the arginine deiminase operon, and identified sequence polymorphisms and plasmid differences between USA300 isolates.

Conclusions:

  • USA300-MRSA shares high genomic similarity with other MRSA strains, suggesting subtle genetic changes drive its pathogenesis.
  • Differences in plasmid content and sequence polymorphisms between USA300 isolates offer insights into pathogen evolution.
  • Further research into these subtle genetic variations is crucial for understanding USA300's dominance and virulence.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...